NCT02305888View on ClinicalTrials.gov

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

PHASE2CompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions

Actinic Keratosis

Interventions

DRUG

LEO 43204

Treatment of actinic keratosis

Trial Locations (1)

11787

Long Island Skin Cancer and Dermatologic Surgery, Smithtown

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY